Medinol goes after J&J's Cordis in stent patent war

August 28, 2013 by Brad Perriello

Medinol, which wrung a $750 million patent infringement decision from Boston Scientific in 2005, sues Johnson & Johnson's Cordis stent making arm.

Medinol goes after J&J's Cordis in stent patent war

Cordis Corp., the stent-making arm of Johnson & Johnson (NYSE:JNJ), got out of the coronary stent game 2 years ago, but that's not stopping Israeli medical device company Medinol from suing Cordis for patent infringement with the Cypher and Cypher Select stents it no longer makes.

Medinol, which won a $750 million decision over erstwhile partner Boston Scientific (NYSE:BSX) in 2005, accused Cordis in March of violating 4 of its patents with the Cypher stents, according to court documents and regulatory filings.

The lawsuit, filed in the U.S. District Court for Southern New York, seeks a jury trial, judgments of infringement and willful infringement, damages and triple damages for willful infringement, legal fees and pre- and post-judgment interest, according to the documents. The patents cited cover articulated stent technology.

Sign up to get our free newsletters delivered straight to your inbox

For its part, Johnson & Johnson argued that it never sold any of the Cypher products and asked Judge Judge Shira Scheindlin to dismiss the case. Barring that, J&J wants the judge to rule against infringement and to find the patents invalid, according to its counter-claim.